EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Comparative study of droplet-digital PCR and absolute Q digital PCR for ctDNA detection in early-stage breast cancer patients

Victoria Sánchez-Martín, Esperanza López-López, Diego Reguero-Paredes, Ana Godoy-Ortiz, Maria Emilia Domínguez-Recio, Begoña Jiménez-Rodríguez, Alfonso Alba-Bernal, Maria Elena Quirós-Ortega, María Dunia Roldán-Díaz, Jesús Velasco-Suelto, Noelia Linares-Valencia, Alicia Garrido-Aranda und 5 weitere

Clinica Chimica Acta · 2024-01 · 552 · 117673

DOI: 10.1016/j.cca.2023.117673 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinica Chimica Acta, 2024-01. Verfasst von Victoria Sánchez-Martín und 16 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; Centro …. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Circulating Tumor DNA, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Analysis of circulating tumor DNA (ctDNA) is increasingly used for clinical decision-making in oncology. However, ctDNA could represent ≤ 0.1 % of cell-free DNA in early-stage tumors and its detection requires high-sensitive techniques such as digital PCR (dPCR). METHODS: In 46 samples from patients with early-stage breast cancer, we compared two leading dPCR assays for ctDNA analysis: QX200 droplet digital PCR (ddPCR) system from Bio-Rad which is the gold-standard in the field, and Absolute Q plate-based digital PCR (pdPCR) system from Thermo Fisher Scientific which has not been reported before. We analyzed 5 mL of baseline plasma samples prior to any treatment. RESULTS: Both systems displayed a comparable sensitivity with no significant differences observed in mutant allele frequency. In fact, ddPCR and pdPCR possessed a concordance > 90 % in ctDNA positivity. Nevertheless, ddPCR exhibited higher variability and a longer workflow. Finally, we explored the association between ctDNA levels and clinicopathological features. Significantly higher ctDNA levels were present in patients with a Ki67 score > 20 % or with estrogen receptor-negative or triple-negative breast cancer subtypes. CONCLUSION: Both ddPCR and pdPCR may constitute sensitive and reliable tools for ctDNA analysis with an adequate agreement in early-stage breast cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell-Free Nucleic AcidsCirculating Tumor DNATriple Negative Breast NeoplasmsHumansBiomarkers, TumorMutationPolymerase Chain Reaction

Stichwörter der Autor:innen

Breast cancerCirculating tumor DNADigital PCRLiquid biopsy

Substanzen

Biomarkers, TumorCell-Free Nucleic AcidsCirculating Tumor DNA

Autor:innen und Institutionen

  • Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; Centro de Investigacion Biomedica en Red de Cancer (CIBERONC - CB16/12/00481)…
  • Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain; The Biomedical Research Institute of Málaga (IBIMA-CIMES-UMA), 29010, Malaga,…
  • Unidad de Gestion Clinica Intercentros de Oncologia Medica, Hospitales Universitarios Regional y Virgen de la Victoria, 29010, Malaga, Spain.

Zitieren

APA

Sánchez-Martín, V., López-López, E., Reguero-Paredes, D., Godoy-Ortiz, A., Domínguez-Recio, M. E., Jiménez-Rodríguez, B., Alba-Bernal, A., Elena Quirós-Ortega, M., Roldán-Díaz, M. D., Velasco-Suelto, J., Linares-Valencia, N., Garrido-Aranda, A., Lavado-Valenzuela, R., Álvarez, M., Pascual, J., Alba, E., & Comino-Méndez, I. (2024). Comparative study of droplet-digital PCR and absolute Q digital PCR for ctDNA detection in early-stage breast cancer patients. Clinica Chimica Acta, 552, 117673. https://doi.org/10.1016/j.cca.2023.117673

Vancouver

Sánchez-Martín V, López-López E, Reguero-Paredes D, Godoy-Ortiz A, Domínguez-Recio ME, Jiménez-Rodríguez B, et al. Comparative study of droplet-digital PCR and absolute Q digital PCR for ctDNA detection in early-stage breast cancer patients. Clinica Chimica Acta. 2024;552:117673. doi:10.1016/j.cca.2023.117673

BibTeX
@article{SnchezMartn2024,
  author = {Sánchez-Martín, Victoria and López-López, Esperanza and Reguero-Paredes, Diego and Godoy-Ortiz, Ana and Domínguez-Recio, Maria Emilia and Jiménez-Rodríguez, Begoña and Alba-Bernal, Alfonso and Elena Quirós-Ortega, Maria and Roldán-Díaz, María Dunia and Velasco-Suelto, Jesús and Linares-Valencia, Noelia and Garrido-Aranda, Alicia and Lavado-Valenzuela, Rocío and Álvarez, Martina and Pascual, Javier and Alba, Emilio and Comino-Méndez, Iñaki},
  title = {Comparative study of droplet-digital PCR and absolute Q digital PCR for ctDNA detection in early-stage breast cancer patients},
  journal = {Clinica Chimica Acta},
  year = {2024},
  volume = {552},
  pages = {117673},
  doi = {10.1016/j.cca.2023.117673}
}
Kostenlos starten →